MIRA INFORM REPORT
|
Report Date : |
23.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
SUNG WOO CHEMICAL CO., LTD. |
|
|
|
|
Registered Office : |
1407-6, Hagil-ri, Hyangnam-eup, Hwaseong-si, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Date of Incorporation : |
27.11.2001 |
|
|
|
|
Com. Reg. No.: |
124-81-91048 |
|
|
|
|
Legal Form : |
Co., Ltd by shares |
|
|
|
|
Line of Business : |
Wholesaler of Pharmaceuticals |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Basic
|
Company
Name |
SUNG WOO CHEMICAL CO., LTD. (Korean Company Name : “성우화학(주)”) |
|
Registered Address |
1407-6,
Hagil-ri, Hyangnam-eup, Hwaseong-si, |
|
Building |
D34-7, Baran Local Industrial Complex |
|
Zip Code |
445-944 |
|
Tel |
+82-31-359-8616 |
|
Fax |
+82-31-359-9664 |
|
E-mail |
|
|
Website |
|
|
Trading Address |
4FL.,
Daelim Office Valley, 97-3, Guro-6-dong, Guro-gu, |
|
Tel |
+82-2-854-3322 |
|
Fax |
+82-2-855-4239 |
|
Type |
Export |
|
Industry |
Wholesale of Pharmaceuticals |
|
Main Business |
Digest Enzyme, Pharmaceutical Raw
Materials, Other Chemicals, Raw Materials for Cosmetics, Food Additives |
|
Established (mm/dd/yyyy) |
11/27/2001 |
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Drugs and Pharmaceutical Products(51000000) |
CEO’s
|
Name |
Yoon Young-Bong |
|
Address |
|
|
Date of Birth |
11/05/1950 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital (KRW) |
200,000,000 |
||||||||||||||||||
|
Employees |
28 |
||||||||||||||||||
|
Formation |
Co., Ltd by shares |
||||||||||||||||||
|
Bank Details |
Shin Han Bank 120 Taepyungno 2 Ga, Jung-Gu, Tel: +82-2-7560505 Industrial Bank of Korea- Daelim Dong Branch |
||||||||||||||||||
|
Corporate Registered No. |
134811-0065484 |
||||||||||||||||||
|
Business Registered No. |
124-81-91048 |
||||||||||||||||||
|
Permit & Licenses |
Int’l Trade No.: 11784766 |
||||||||||||||||||
|
Shareholder Position |
|
||||||||||||||||||
|
Company History |
11/27/2001 Incorporated as the present name 04/03/2003 Increased the authorized shares
to 1,000,000 shares from 40,000 shares 04/05/2003 Increased capital to 200,000,000
KRW from 50,000,000 KRW 03/10/2007 Moved to the present HQ address
from 1443-10, Suchon-ri, Jangan-myeon, Hwaseong-si, Gyeonggi-do, |
||||||||||||||||||
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Yoon Young-Bong |
Male |
Korean |
11/27/2001 |
|
Director |
M/S. |
Kim Yeok-Hee |
Female |
Korean |
03/10/2004 |
|
Auditor |
M/S. |
Choi Mi-Ae |
Female |
Korean |
03/10/2004 |
Financials
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
15,176,270,894 |
13,834,668,676 |
766,233,990 |
|
|
2008 |
13,409,332,851 |
13,133,381,467 |
650,093,436 |
|
2007 |
13,007,295,383 |
12,713,362,499 |
656,451,925 |
|
2006 |
12,194,294,978 |
11,217,461,237 |
1,792,034,683 |
Financial Description
|
Authorized Capital(KRW) |
5,000,000,000 |
|
Paid-Up Capital(KRW) |
200,000,000 |
|
Total Issues Shares |
40,000 |
Balance Sheet
|
Unit : Korean Won |
As of 12/31/2009 |
As of 12/31/2008 |
As of 12/31/2007 |
|
Total Assets |
13,834,668,676 |
13,133,381,467 |
12,713,362,499 |
|
Current Assets |
10,757,072,355 |
9,907,428,186 |
9,167,452,969 |
|
-Quick Assets |
9,440,562,976 |
8,325,346,647 |
7,438,951,955 |
|
-Inventories |
1,316,509,379 |
1,582,081,539 |
1,728,501,014 |
|
Fixed Assets |
3,077,596,321 |
3,225,953,281 |
3,545,909,530 |
|
-Investment |
144,346,051 |
83,824,999 |
28,303,947 |
|
-Tangibles |
2,839,626,910 |
3,007,022,922 |
3,382,500,223 |
|
-Intangibles |
93,623,360 |
135,105,360 |
135,105,360 |
|
Total Liabilities |
8,131,986,503 |
8,196,933,284 |
8,427,007,752 |
|
Current Liabilities |
7,631,986,503 |
7,384,510,874 |
8,211,356,998 |
|
Fixed Liabilities |
500,000,000 |
812,422,410 |
215,650,754 |
|
Capital Stock |
200,000,000 |
200,000,000 |
200,000,000 |
|
Capital Surplus |
- |
- |
- |
|
Profit Surplus |
5,502,682,173 |
4,736,448,183 |
4,086,354,747 |
|
Capital Adjustment |
- |
- |
- |
|
Total Equity |
5,702,682,173 |
4,936,448,183 |
4,286,354,747 |
|
Liab. & Shareholder’s Equity |
13,834,668,676 |
13,133,381,467 |
12,713,362,499 |
|
Current
Liabilities |
7,631,986,503 |
7,384,510,874 |
8,211,356,998 |
|
Trade Payables |
979,329,012 |
593,265,151 |
415,876,996 |
|
Account Payables |
912,170,679 |
518,221,191 |
522,416,301 |
|
Short-Term Borrowings |
2,860,000,000 |
2,860,000,000 |
3,360,000,000 |
|
Advance Receipts |
750,650 |
9,165,000 |
3,341,800 |
|
Withholdings |
22,730,150 |
10,118,640 |
11,291,070 |
|
Accrued Income Tax |
73,829,510 |
- |
- |
|
Accrued
Expenses |
59,495,190 |
161,366,970 |
253,483,117 |
|
Short-Term Borrowings to
Shareholders/Executives/Employees |
2,718,255,875 |
3,224,624,218 |
3,637,901,676 |
|
Accrued Expenses |
5,425,437 |
7,749,704 |
7,046,038 |
|
Fixed
Liabilities |
500,000,000 |
812,422,410 |
215,650,754 |
|
Long-Term
Borrowings |
500,000,000 |
500,000,000 |
- |
|
Provision for Severance & Retirement |
- |
312,422,410 |
215,650,754 |
Income Statement
|
Unit : Korean Won |
As of 12/31/2009 |
As of 12/31/2008 |
As of 12/31/2007 |
|
Sales |
15,176,270,894 |
13,409,332,851 |
13,007,295,383 |
|
Cost of Sold Goods |
13,189,294,357 |
11,442,015,418 |
11,127,352,144 |
|
Gross Profit |
1,986,976,537 |
1,967,317,433 |
1,879,943,239 |
|
Selling & Admin. Expenses |
862,262,187 |
726,055,126 |
724,492,453 |
|
Operating Income |
1,124,714,350 |
1,241,262,307 |
1,155,450,786 |
|
Non-Operating Income |
73,041,318 |
63,319,435 |
23,755,290 |
|
Non-Operating Expenses |
277,220,358 |
447,504,733 |
271,652,374 |
|
Ordinary Income |
920,535,310 |
857,077,009 |
907,553,702 |
|
Special Income |
- |
- |
- |
|
Income Before Taxes |
920,535,310 |
857,077,009 |
907,553,702 |
|
Income Taxes Expenses |
154,301,320 |
206,983,573 |
251,101,777 |
|
Net Income |
766,233,990 |
650,093,436 |
656,451,925 |
Cash Flows
|
Unit : Korean Won |
As of 12/31/2009 |
As of 12/31/2008 |
As of 12/31/2007 |
|
Cash Flows from Operating |
632,938,800 |
530,034,726 |
-318,853,296 |
|
-Net Income |
766,233,990 |
650,093,436 |
656,451,925 |
|
-Exp. without Cash Outflow |
427,879,112 |
562,429,275 |
657,161,536 |
|
- |
- |
- |
-589,480 |
|
-Changes in Asset/ & Liability |
-561,174,302 |
-682,487,985 |
-1,631,877,277 |
|
Cash Flows from Investing |
-111,979,409 |
-8,327,131 |
-1,021,090,463 |
|
-Cash Inflow from Investing |
65,482,000 |
97,345,240 |
663,557,370 |
|
-Cash Outflows for Investing |
-177,461,409 |
-105,672,371 |
-1,684,647,833 |
|
Cash Flows from Financing |
-506,368,343 |
-413,277,458 |
1,009,631,290 |
|
-Cash Inflows from Financing |
733,000,000 |
47,506,795 |
1,379,202,460 |
|
-Cash Outflows from Financing |
-1,239,368,343 |
-460,784,253 |
-369,571,170 |
|
Increase/Decrease in Cash |
14,591,048 |
108,430,137 |
-330,312,469 |
|
Cash at the Beginning of Year |
285,024,948 |
176,594,811 |
506,907,280 |
|
Cash at the End of Year |
299,615,996 |
285,024,948 |
176,594,811 |
Products, Technologies, Services Description
|
Main Products & Services |
Digest Enzyme, Pharmaceutical Raw
Materials, Other Chemicals, Raw Materials for Cosmetics, Food Additives |
Trade Partners & Competitors
|
Competitors |
DREAM PHARMA CO., LTD. 13TH FL., HANHWA BLDG., 1, JANGGYO-DONG,
JUNG-GU, TEL:+82-2-729-4115 FAX:+82-2-729-4127~8 KOREAN DRUG CO., LTD. 486, SUGWANG 1-RI, SINDUN-MYEON, ICHEON-SI,
TEL:+82-31-634-7100~2 FAX:+82-31-634-7103 BIOCHEM 4TH FL., MYEONGMUN BLDG., 946-18, DOGOK
1-DONG, GANGNAM-GU, TEL:+82-2-992-2013 FAX:+82-2-992-2046 |
Related Parties
(Subsidiaries, Joint-Venture & Affiliates)
|
Cooperative |
-Insured Company LOTTE NON-LIFE INSURANCE CO., LTD.(110111-0014459) SAMSUNG FIRE & MARINE INSURANCE CO., LTD(110111-0005078) |
Sales by Region
(Activity & Markets)
The Subject exports
to
Court Action
No.
News Clipping
----
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.20 |
|
|
1 |
Rs.73.07 |
|
Euro |
1 |
Rs.61.41 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.